See more : WisdomTree Industrial Metals Enhanced (META.L) Income Statement Analysis – Financial Results
Complete financial analysis of Philip Morris International Inc. (PM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Philip Morris International Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
- Healthcare Trust, Inc. (HTIBP) Income Statement Analysis – Financial Results
- Shenzhen Capstone Industrial Co.,Ltd. (000038.SZ) Income Statement Analysis – Financial Results
- Nexion Technologies Limited (8420.HK) Income Statement Analysis – Financial Results
- Grand Green Energy Co., LTD. (6639.TWO) Income Statement Analysis – Financial Results
- Score Media and Gaming Inc. (SCR.TO) Income Statement Analysis – Financial Results
Philip Morris International Inc. (PM)
About Philip Morris International Inc.
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 35.17B | 31.76B | 31.41B | 28.69B | 29.81B | 29.63B | 28.75B | 26.69B | 26.79B | 29.77B | 31.22B | 31.38B | 31.10B | 27.21B | 25.04B | 25.71B | 22.80B | 48.26B | 45.29B | 33.39B | 8.10B |
Cost of Revenue | 12.89B | 11.23B | 10.03B | 9.57B | 10.51B | 10.76B | 10.43B | 9.39B | 9.37B | 10.44B | 10.41B | 10.37B | 10.68B | 9.71B | 9.02B | 9.33B | 8.72B | 35.62B | 32.92B | 23.82B | 2.81B |
Gross Profit | 22.28B | 20.53B | 21.38B | 19.13B | 19.29B | 18.87B | 18.32B | 17.29B | 17.43B | 19.33B | 20.81B | 21.00B | 20.42B | 17.50B | 16.01B | 16.38B | 14.08B | 12.64B | 12.37B | 9.57B | 5.30B |
Gross Profit Ratio | 63.35% | 64.65% | 68.06% | 66.65% | 64.73% | 63.69% | 63.71% | 64.81% | 65.05% | 64.94% | 66.65% | 66.94% | 65.66% | 64.30% | 63.96% | 63.71% | 61.75% | 26.19% | 27.31% | 28.66% | 65.36% |
Research & Development | 709.00M | 642.00M | 617.00M | 495.00M | 465.00M | 383.00M | 453.00M | 429.00M | 423.00M | 433.00M | 449.00M | 415.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 10.11B | 8.14B | 8.52B | 7.48B | 8.78B | 7.45B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | -148.00M | 8.30B | 7.38B | 8.70B | 7.41B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 10.11B | 7.99B | 8.30B | 7.41B | 8.17B | 7.45B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.96B | 6.88B | 6.16B | 5.87B | 6.00B | 5.02B | 4.57B | 4.54B | 3.37B | 0.00 |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -41.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.00M | 88.00M | 74.00M | 44.00M | 28.00M | 0.00 | 90.00M | 0.00 | 0.00 |
Operating Expenses | 10.63B | 8.18B | 8.37B | 7.54B | 8.70B | 7.47B | 6.75B | 6.39B | 6.70B | 7.52B | 7.31B | 7.16B | 6.98B | 6.25B | 5.94B | 6.05B | 5.05B | 4.27B | 4.63B | 3.37B | 2.35B |
Cost & Expenses | 23.62B | 19.40B | 18.40B | 17.11B | 19.21B | 18.23B | 17.19B | 15.78B | 16.07B | 17.96B | 17.72B | 17.53B | 17.66B | 15.96B | 14.97B | 15.37B | 13.77B | 39.89B | 37.55B | 27.19B | 5.16B |
Interest Income | 465.00M | 180.00M | 109.00M | 110.00M | 226.00M | 190.00M | 182.00M | 178.00M | 124.00M | 118.00M | 131.00M | 148.00M | 134.00M | 98.00M | 108.00M | 217.00M | 0.00 | 229.00M | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.53B | 768.00M | 737.00M | 728.00M | 570.00M | 665.00M | 914.00M | 891.00M | 1.13B | 1.17B | 1.10B | 1.01B | 800.00M | 974.00M | 797.00M | 528.00M | 10.00M | 371.00M | 94.00M | 0.00 | 146.00M |
Depreciation & Amortization | 1.40B | 1.19B | 998.00M | 981.00M | 964.00M | 989.00M | 875.00M | 743.00M | 754.00M | 889.00M | 882.00M | 898.00M | 98.00M | 932.00M | 853.00M | 44.00M | 748.00M | 658.00M | 527.00M | 370.00M | 0.00 |
EBITDA | 13.37B | 13.79B | 14.17B | 12.92B | 11.95B | 12.58B | 12.46B | 11.71B | 11.47B | 12.67B | 14.48B | 14.85B | 14.48B | 12.19B | 10.94B | 11.09B | 9.64B | 9.23B | 8.26B | 6.57B | 2.95B |
EBITDA Ratio | 38.02% | 42.88% | 44.81% | 44.26% | 40.34% | 41.60% | 43.06% | 43.31% | 42.71% | 44.10% | 47.11% | 47.31% | 43.89% | 45.12% | 43.63% | 40.69% | 43.57% | 18.08% | 18.44% | 19.67% | 36.36% |
Operating Income | 12.70B | 12.54B | 13.08B | 11.72B | 11.06B | 11.34B | 11.50B | 10.82B | 10.69B | 12.24B | 13.82B | 13.95B | 13.33B | 11.20B | 10.04B | 10.25B | 8.87B | 8.37B | 7.74B | 6.20B | 2.95B |
Operating Income Ratio | 36.10% | 39.49% | 41.64% | 40.84% | 37.10% | 38.26% | 40.01% | 40.53% | 39.90% | 41.11% | 44.28% | 44.45% | 42.87% | 41.16% | 40.10% | 39.87% | 38.92% | 17.34% | 17.08% | 18.56% | 36.36% |
Total Other Income/Expenses | -2.09B | -773.00M | -695.00M | -751.00M | -1.04B | -605.00M | -855.00M | -797.00M | -971.00M | -947.00M | -995.00M | -959.00M | -810.00M | -876.00M | -797.00M | -311.00M | -49.00M | -124.00M | -94.00M | 17.00M | -179.00M |
Income Before Tax | 10.61B | 11.77B | 12.38B | 10.97B | 10.02B | 10.73B | 10.65B | 10.02B | 9.72B | 10.76B | 12.52B | 12.99B | 12.53B | 10.32B | 9.24B | 9.94B | 8.86B | 8.23B | 7.64B | 6.21B | 2.77B |
Income Before Tax Ratio | 30.16% | 37.06% | 39.42% | 38.23% | 33.62% | 36.22% | 37.04% | 37.54% | 36.28% | 36.13% | 40.11% | 41.39% | 40.30% | 37.94% | 36.92% | 38.66% | 38.88% | 17.05% | 16.87% | 18.61% | 34.16% |
Income Tax Expense | 2.34B | 2.24B | 2.67B | 2.38B | 2.29B | 2.45B | 4.31B | 2.77B | 2.69B | 3.10B | 3.67B | 3.83B | 3.65B | 2.83B | 2.69B | 2.79B | 2.56B | 1.83B | 1.84B | 2.09B | 593.00M |
Net Income | 7.79B | 9.05B | 9.11B | 8.06B | 7.19B | 7.91B | 6.04B | 6.97B | 6.87B | 7.49B | 8.58B | 8.80B | 8.59B | 7.26B | 6.34B | 6.89B | 6.03B | 6.15B | 5.62B | 3.98B | 2.23B |
Net Income Ratio | 22.15% | 28.49% | 29.00% | 28.08% | 24.11% | 26.70% | 20.99% | 26.11% | 25.65% | 25.17% | 27.47% | 28.05% | 27.63% | 26.68% | 25.33% | 26.80% | 26.43% | 12.74% | 12.41% | 11.91% | 27.50% |
EPS | 5.02 | 5.82 | 5.83 | 5.16 | 4.61 | 5.09 | 3.88 | 4.48 | 4.42 | 4.76 | 5.26 | 5.17 | 4.98 | 3.93 | 3.25 | 3.33 | 2.86 | 2.91 | 2.71 | 1.96 | 1.34 |
EPS Diluted | 5.02 | 5.81 | 5.83 | 5.16 | 4.61 | 5.09 | 3.88 | 4.48 | 4.42 | 4.76 | 5.26 | 5.17 | 4.98 | 3.92 | 3.24 | 3.32 | 2.86 | 2.91 | 2.69 | 1.95 | 1.34 |
Weighted Avg Shares Out | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.73B | 1.84B | 1.94B | 2.07B | 2.11B | 2.11B | 2.07B | 2.03B | 0.00 |
Weighted Avg Shares Out (Dil) | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.73B | 1.84B | 1.95B | 2.08B | 2.11B | 2.11B | 2.09B | 2.04B | 0.00 |
2 High-Yield Dividend Stocks I Can't Stop Buying
The Zacks Analyst Blog JPMorgan, Philip Morris and The Progressive
The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco
3 Tobacco Stocks to Watch as Smoke-Free Trends Ignite Growth
FDA Reauthorizes Swedish Match's General snus as a Modified Risk Tobacco Product
1 Magnificent Dividend Growth Stock That Can Outperform the S&P 500
1 Magnificent Stock Billionaire Stan Druckenmiller Is Adding To His Portfolio
Tobacco Stock Could Take a Breather From Highs
The 2 Dividend Stocks To Own When Inflation Rips Back
Philip Morris (PM) Is Up 8.03% in One Week: What You Should Know
Source: https://incomestatements.info
Category: Stock Reports